PeriRx tackles development of saliva-based Rx cancer test; CryoLife resolves lawsuit

 @FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

> Sanovas has secured its first U.S. patent toward the development of a device that would remove tissue growths and tumors "in hard-to-reach bodily cavities" to help treat lung cancer. Release

> PeriRx is developing a non-invasive saliva text that dentists can use to both detect and predict oral cancer. Story

> SQI Diagnostics in Toronto has raised the third and final tranche of a more than $5.65 million non-brokered private placement. Release

> CryoLife ($CRY), a medical device company focused on cardiac and vascular surgery, will receive $3.5 million as part of a settlement of its pending lawsuit against Medafor. Release

> Medical devicemakers are helping to boost demand for small businesses that make machines and components for other manufacturers, pointing to a positive sign for the broader economy. Story

> Boston Scientific's ($BSX) recent acquisition of Cameron Health brought the company a subcutaneous ICD, and MassDevice's Dr. Westby Fisher writes that the tech injects some much-needed originality into Boston Sci's CRM unit. Column

Biotech News

 @FierceBiotech: After death, some stem cells remain alive for days. More | Follow @FierceBiotech

 @RyanMFierce: Human Genome Sciences sets deadline of July 16 for acquisition offers, but not sure how that motivates non-GSK buyers. More | Follow @RyanMFierce

> Pfizer ramps up work with academics and biotech startups. Story

> HGS to GSK: Play by our buyout rules. More

> GSK grabs FDA nod for combo meningitis vax. News

> Bristol taps drug chemistry whizzes at Scripps. Article

Pharma News

 @FiercePharma: NICE tells Roche Zelboraf is too expensive. More | Follow @FiercePharma

> Feds nail Internet pharmacy operator for fake drugs. News

> HGS sets deadline for bids: Come and get it! Story

> Drugmakers line up for tsunami of diabetes. More

And Finally... Link-age, a 17-year-old Cincinnati-area nonprofit, is planning to raise as much as $20 million to establish a national venture fund focused on products and services relating to aging, the Business Courier reports. (sub. req.) Story

Suggested Articles

The randomized, blinded study showed statistically significant improvements in assessments of inattention and brain activity.

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.